Crystal Structure
Crystallisation Method: X-ray
Corresponding Chain: A/B
Sequence Length: 41-315
Detail: Struture Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0545 | ||||
| Gene Name | KCNK2 | ||||
| Protein Name | Potassium channel subfamily K member 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Crystal Structure Crystallisation Method: X-ray Corresponding Chain: A/B Sequence Length: 41-315 Detail: Struture Info |
||||
| Synonyms | Outward rectifying potassium channel protein TREK-1; TREK-1 K(+) channel subunit; Two pore domain potassium channel TREK-1; Two pore potassium channel TPKC1 | ||||
| DT Family | Voltage-gated Ion Channel (VIC) Superfamily ; | ||||
| Tissue Specificity | Isoform 4 is detected in kidney, adrenal gland and brain where it is preferentially expressed in the amygdala but not found in thalamus, hypothalamus, hippocampus or substantia nigra. | ||||
| Function | This transporter can reversibly converts between a voltage-insensitive potassium leak channel and a voltage-dependent outward rectifying potassium channel in a phosphorylation-dependent manner. Ion channel that contributes to passive transmembrane potassium transport. | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.